

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.78575961 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.55402181 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.55402181 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.49750377 |
| 5 | glycosphingolipid catabolic process (GO:0046479) | 4.49575289 |
| 6 | NIK/NF-kappaB signaling (GO:0038061) | 4.41435852 |
| 7 | immunoglobulin mediated immune response (GO:0016064) | 4.35848125 |
| 8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.32143405 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 4.29662762 |
| 10 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.17417002 |
| 11 | negative regulation of cell killing (GO:0031342) | 4.16088454 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.16088454 |
| 13 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.16079049 |
| 14 | oligosaccharide catabolic process (GO:0009313) | 4.16066870 |
| 15 | detection of other organism (GO:0098543) | 4.13190056 |
| 16 | amino sugar catabolic process (GO:0046348) | 4.08849123 |
| 17 | regulation of mononuclear cell migration (GO:0071675) | 4.05292803 |
| 18 | positive regulation of mast cell activation (GO:0033005) | 4.05046890 |
| 19 | glycolipid catabolic process (GO:0019377) | 4.04430823 |
| 20 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.04094726 |
| 21 | detection of molecule of bacterial origin (GO:0032490) | 3.96736931 |
| 22 | positive regulation of antigen processing and presentation (GO:0002579) | 3.96304564 |
| 23 | positive regulation of interferon-alpha production (GO:0032727) | 3.93972804 |
| 24 | positive regulation by symbiont of host defense response (GO:0052509) | 3.88995083 |
| 25 | modulation by symbiont of host defense response (GO:0052031) | 3.88995083 |
| 26 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.88995083 |
| 27 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.88995083 |
| 28 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.88995083 |
| 29 | modulation by symbiont of host immune response (GO:0052553) | 3.88995083 |
| 30 | detection of bacterium (GO:0016045) | 3.84764660 |
| 31 | T-helper 1 type immune response (GO:0042088) | 3.78160187 |
| 32 | detection of external biotic stimulus (GO:0098581) | 3.77711726 |
| 33 | B cell receptor signaling pathway (GO:0050853) | 3.75315968 |
| 34 | regulation of interferon-alpha production (GO:0032647) | 3.70113587 |
| 35 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.68186753 |
| 36 | ceramide catabolic process (GO:0046514) | 3.58613763 |
| 37 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.57218889 |
| 38 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.55972111 |
| 39 | natural killer cell mediated immunity (GO:0002228) | 3.55972111 |
| 40 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.55625748 |
| 41 | regulation of leukocyte degranulation (GO:0043300) | 3.51624584 |
| 42 | regulation of antigen processing and presentation (GO:0002577) | 3.50941709 |
| 43 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.50610957 |
| 44 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.50357243 |
| 45 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.49908006 |
| 46 | N-acetylneuraminate metabolic process (GO:0006054) | 3.48986991 |
| 47 | regulation of mast cell activation (GO:0033003) | 3.48849296 |
| 48 | macrophage activation involved in immune response (GO:0002281) | 3.48806440 |
| 49 | neutrophil activation (GO:0042119) | 3.47258987 |
| 50 | cellular response to zinc ion (GO:0071294) | 3.46810480 |
| 51 | B cell mediated immunity (GO:0019724) | 3.46156476 |
| 52 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.45156123 |
| 53 | respiratory burst (GO:0045730) | 3.41780915 |
| 54 | macrophage activation (GO:0042116) | 3.39648368 |
| 55 | regulation of B cell differentiation (GO:0045577) | 3.34534839 |
| 56 | granulocyte activation (GO:0036230) | 3.34078460 |
| 57 | regulation of macrophage chemotaxis (GO:0010758) | 3.33799314 |
| 58 | detection of biotic stimulus (GO:0009595) | 3.33617844 |
| 59 | response to thyroid hormone (GO:0097066) | 3.29952898 |
| 60 | positive regulation of B cell differentiation (GO:0045579) | 3.28659883 |
| 61 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.27504037 |
| 62 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.25281364 |
| 63 | response to peptidoglycan (GO:0032494) | 3.20523715 |
| 64 | microglial cell activation (GO:0001774) | 3.16976995 |
| 65 | myeloid dendritic cell differentiation (GO:0043011) | 3.13107012 |
| 66 | myeloid dendritic cell activation (GO:0001773) | 3.07565584 |
| 67 | regulation of T cell tolerance induction (GO:0002664) | 3.07004979 |
| 68 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.04558921 |
| 69 | hepatocyte apoptotic process (GO:0097284) | 3.02407059 |
| 70 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.97080306 |
| 71 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.95726214 |
| 72 | response to muramyl dipeptide (GO:0032495) | 2.93938669 |
| 73 | negative regulation of B cell proliferation (GO:0030889) | 2.93650970 |
| 74 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.93252075 |
| 75 | membrane lipid catabolic process (GO:0046466) | 2.93010344 |
| 76 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.92655977 |
| 77 | regulation of monocyte chemotaxis (GO:0090025) | 2.90968659 |
| 78 | positive regulation of interferon-beta production (GO:0032728) | 2.89497773 |
| 79 | phagosome maturation (GO:0090382) | 2.89477740 |
| 80 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.89441930 |
| 81 | response to host immune response (GO:0052572) | 2.89441930 |
| 82 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.88133457 |
| 83 | regulation of tolerance induction (GO:0002643) | 2.87609279 |
| 84 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 2.85012716 |
| 85 | positive regulation of type 2 immune response (GO:0002830) | 2.84167990 |
| 86 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.83819716 |
| 87 | leukocyte mediated cytotoxicity (GO:0001909) | 2.83118752 |
| 88 | regulation of cholesterol storage (GO:0010885) | 2.83012475 |
| 89 | sphingolipid catabolic process (GO:0030149) | 2.82976297 |
| 90 | dendritic cell differentiation (GO:0097028) | 2.82781166 |
| 91 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.82713299 |
| 92 | regulation of podosome assembly (GO:0071801) | 2.79435146 |
| 93 | regulation of regulated secretory pathway (GO:1903305) | 2.79034518 |
| 94 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.78576897 |
| 95 | mature B cell differentiation (GO:0002335) | 2.78564917 |
| 96 | regulation of hypersensitivity (GO:0002883) | 2.77634878 |
| 97 | pinocytosis (GO:0006907) | 2.77629793 |
| 98 | * cellular response to interferon-gamma (GO:0071346) | 2.77522517 |
| 99 | germinal center formation (GO:0002467) | 2.77036201 |
| 100 | monocyte chemotaxis (GO:0002548) | 2.76950881 |
| 101 | response to protozoan (GO:0001562) | 2.76713653 |
| 102 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.76527486 |
| 103 | lymphocyte mediated immunity (GO:0002449) | 2.74283092 |
| 104 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.73982932 |
| 105 | response to type I interferon (GO:0034340) | 2.72612856 |
| 106 | positive regulation of protein oligomerization (GO:0032461) | 2.71328142 |
| 107 | cellular response to type I interferon (GO:0071357) | 2.70416169 |
| 108 | type I interferon signaling pathway (GO:0060337) | 2.70416169 |
| 109 | positive regulation of interleukin-12 production (GO:0032735) | 2.66128782 |
| 110 | actin nucleation (GO:0045010) | 2.63618577 |
| 111 | regulation of RIG-I signaling pathway (GO:0039535) | 2.63033522 |
| 112 | cellular response to interferon-beta (GO:0035458) | 2.62800343 |
| 113 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.62782996 |
| 114 | negative regulation of interleukin-12 production (GO:0032695) | 2.62001406 |
| 115 | regulation of B cell apoptotic process (GO:0002902) | 2.61636191 |
| 116 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.60035402 |
| 117 | interferon-gamma secretion (GO:0072643) | 2.59825133 |
| 118 | negative regulation of phagocytosis (GO:0050765) | 2.59442805 |
| 119 | regulation of interleukin-12 production (GO:0032655) | 2.56808822 |
| 120 | regulation of mast cell degranulation (GO:0043304) | 2.55269644 |
| 121 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.53472336 |
| 122 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.53452508 |
| 123 | regulation of gamma-delta T cell activation (GO:0046643) | 2.53045095 |
| 124 | defense response to protozoan (GO:0042832) | 2.52393968 |
| 125 | regulation of superoxide anion generation (GO:0032928) | 2.51699151 |
| 126 | positive thymic T cell selection (GO:0045059) | 2.49133849 |
| 127 | regulation of B cell proliferation (GO:0030888) | 2.47334097 |
| 128 | viral transcription (GO:0019083) | 2.47232531 |
| 129 | ribosomal small subunit assembly (GO:0000028) | 2.45524087 |
| 130 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.44931560 |
| 131 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.43257321 |
| 132 | regulation of interferon-beta production (GO:0032648) | 2.42412640 |
| 133 | myeloid cell activation involved in immune response (GO:0002275) | 2.42387440 |
| 134 | T cell migration (GO:0072678) | 2.42026791 |
| 135 | negative regulation of granulocyte differentiation (GO:0030853) | 2.41877718 |
| 136 | cellular response to exogenous dsRNA (GO:0071360) | 2.41675609 |
| 137 | cellular extravasation (GO:0045123) | 2.41416794 |
| 138 | cytokine secretion (GO:0050663) | 2.41212451 |
| 139 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.39773864 |
| 140 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.39629932 |
| 141 | dendritic cell migration (GO:0036336) | 2.37913581 |
| 142 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.37133526 |
| 143 | positive regulation of neutrophil migration (GO:1902624) | 2.36742176 |
| 144 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.36742176 |
| 145 | T cell apoptotic process (GO:0070231) | 2.36529120 |
| 146 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.35854652 |
| 147 | mature B cell differentiation involved in immune response (GO:0002313) | 2.35189841 |
| 148 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.35140514 |
| 149 | positive regulation of mast cell degranulation (GO:0043306) | 2.35140514 |
| 150 | dendritic cell chemotaxis (GO:0002407) | 2.34861489 |
| 151 | positive regulation of leukocyte degranulation (GO:0043302) | 2.34515051 |
| 152 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.33367689 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.30742647 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.30372102 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.24239880 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.23038885 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.17531389 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.93651576 |
| 7 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.76777874 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.59828375 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.50883515 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.50725918 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.49660132 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.45195663 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.34699837 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.32870244 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.26379031 |
| 16 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.22548184 |
| 17 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.18193248 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.12993576 |
| 19 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.09828555 |
| 20 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.08289354 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.98529846 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.96895223 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.96548938 |
| 24 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.95865533 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.94349821 |
| 26 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.93878286 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.92944427 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 1.90276775 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.86456142 |
| 30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.84156647 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.78206218 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.73992382 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.73545465 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.73276080 |
| 35 | MYB_26560356_Chip-Seq_TH2_Human | 1.72233781 |
| 36 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.71572550 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.70766758 |
| 38 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60694478 |
| 39 | MYB_26560356_Chip-Seq_TH1_Human | 1.55511377 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51114869 |
| 41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49987146 |
| 42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49056244 |
| 43 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.46880702 |
| 44 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.46832532 |
| 45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.44337598 |
| 46 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40278991 |
| 47 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40147812 |
| 48 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.39174586 |
| 49 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.34812666 |
| 50 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.33097380 |
| 51 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32848106 |
| 52 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.30831422 |
| 53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.29490182 |
| 54 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25763871 |
| 55 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.25646223 |
| 56 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24808214 |
| 57 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.23915731 |
| 58 | GATA1_22025678_ChIP-Seq_K562_Human | 1.23896466 |
| 59 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.23696096 |
| 60 | MAF_26560356_Chip-Seq_TH2_Human | 1.22647128 |
| 61 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21106682 |
| 62 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21064144 |
| 63 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19084553 |
| 64 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18815269 |
| 65 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.18499230 |
| 66 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.16506164 |
| 67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.15788519 |
| 68 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12722452 |
| 69 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12684430 |
| 70 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10904615 |
| 71 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.10706240 |
| 72 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.08246528 |
| 73 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.08106307 |
| 74 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.06523404 |
| 75 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.05834316 |
| 76 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.05681311 |
| 77 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.05195823 |
| 78 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04875434 |
| 79 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04485646 |
| 80 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04227780 |
| 81 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.03148997 |
| 82 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.02826567 |
| 83 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.02682142 |
| 84 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.02179255 |
| 85 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.01903072 |
| 86 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.01764445 |
| 87 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.00853650 |
| 88 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.99887270 |
| 89 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.99373603 |
| 90 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.98866590 |
| 91 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98679378 |
| 92 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.98293125 |
| 93 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.96966283 |
| 94 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.96644216 |
| 95 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.96577801 |
| 96 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.95085683 |
| 97 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95008247 |
| 98 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94390939 |
| 99 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.94221603 |
| 100 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93894756 |
| 101 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93840450 |
| 102 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92627736 |
| 103 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92401970 |
| 104 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92055076 |
| 105 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.91486533 |
| 106 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91412065 |
| 107 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.91231204 |
| 108 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.90982388 |
| 109 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.90823452 |
| 110 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90742636 |
| 111 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90739744 |
| 112 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90456988 |
| 113 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.90008824 |
| 114 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.89753119 |
| 115 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.89258627 |
| 116 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.89205598 |
| 117 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.88351235 |
| 118 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87915233 |
| 119 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87632850 |
| 120 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.87407721 |
| 121 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.86807233 |
| 122 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85802145 |
| 123 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.84439291 |
| 124 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.80367282 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.43229525 |
| 2 | MP0005387_immune_system_phenotype | 3.03447422 |
| 3 | MP0001790_abnormal_immune_system | 3.03447422 |
| 4 | MP0000685_abnormal_immune_system | 3.02211929 |
| 5 | MP0001800_abnormal_humoral_immune | 2.90860559 |
| 6 | MP0003436_decreased_susceptibility_to | 2.86086173 |
| 7 | MP0003303_peritoneal_inflammation | 2.84184609 |
| 8 | * MP0002452_abnormal_antigen_presenting | 2.66052986 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.61064510 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.50762789 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 2.33926924 |
| 12 | MP0002723_abnormal_immune_serum | 2.28812895 |
| 13 | MP0002419_abnormal_innate_immunity | 2.27798081 |
| 14 | MP0004510_myositis | 2.26052779 |
| 15 | MP0005025_abnormal_response_to | 2.22352613 |
| 16 | MP0005671_abnormal_response_to | 2.20088791 |
| 17 | MP0009785_altered_susceptibility_to | 2.18317770 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.17321027 |
| 19 | MP0001819_abnormal_immune_cell | 2.17282992 |
| 20 | MP0005058_abnormal_lysosome_morphology | 2.16235989 |
| 21 | MP0002166_altered_tumor_susceptibility | 2.07582724 |
| 22 | MP0002139_abnormal_hepatobiliary_system | 2.07286725 |
| 23 | MP0002254_reproductive_system_inflammat | 2.03561575 |
| 24 | MP0010352_gastrointestinal_tract_polyps | 2.01976924 |
| 25 | MP0003806_abnormal_nucleotide_metabolis | 1.93887887 |
| 26 | MP0004947_skin_inflammation | 1.88677564 |
| 27 | MP0001873_stomach_inflammation | 1.87889964 |
| 28 | MP0002405_respiratory_system_inflammati | 1.85749556 |
| 29 | MP0001853_heart_inflammation | 1.84188871 |
| 30 | MP0003300_gastrointestinal_ulcer | 1.81873981 |
| 31 | MP0005310_abnormal_salivary_gland | 1.79150542 |
| 32 | MP0000716_abnormal_immune_system | 1.74883670 |
| 33 | MP0002398_abnormal_bone_marrow | 1.74877335 |
| 34 | MP0003690_abnormal_glial_cell | 1.73884804 |
| 35 | MP0009333_abnormal_splenocyte_physiolog | 1.68475131 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.67995488 |
| 37 | MP0006082_CNS_inflammation | 1.67606934 |
| 38 | MP0002006_tumorigenesis | 1.67452064 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.67030817 |
| 40 | MP0009840_abnormal_foam_cell | 1.66512854 |
| 41 | MP0000689_abnormal_spleen_morphology | 1.58944182 |
| 42 | MP0005451_abnormal_body_composition | 1.57949861 |
| 43 | MP0003705_abnormal_hypodermis_morpholog | 1.54808215 |
| 44 | MP0002429_abnormal_blood_cell | 1.49549186 |
| 45 | MP0002722_abnormal_immune_system | 1.44678054 |
| 46 | MP0008260_abnormal_autophagy | 1.44676429 |
| 47 | MP0003566_abnormal_cell_adhesion | 1.43488734 |
| 48 | MP0005464_abnormal_platelet_physiology | 1.42253260 |
| 49 | MP0005076_abnormal_cell_differentiation | 1.42175355 |
| 50 | MP0003191_abnormal_cellular_cholesterol | 1.40960151 |
| 51 | MP0001533_abnormal_skeleton_physiology | 1.39388736 |
| 52 | MP0010234_abnormal_vibrissa_follicle | 1.37612439 |
| 53 | MP0005166_decreased_susceptibility_to | 1.29083533 |
| 54 | MP0008469_abnormal_protein_level | 1.27924379 |
| 55 | MP0003448_altered_tumor_morphology | 1.27669521 |
| 56 | MP0003172_abnormal_lysosome_physiology | 1.25028847 |
| 57 | MP0003453_abnormal_keratinocyte_physiol | 1.24901645 |
| 58 | MP0000490_abnormal_crypts_of | 1.23867048 |
| 59 | MP0006054_spinal_hemorrhage | 1.22431259 |
| 60 | MP0005167_abnormal_blood-brain_barrier | 1.21363306 |
| 61 | MP0003329_amyloid_beta_deposits | 1.19980503 |
| 62 | MP0000858_altered_metastatic_potential | 1.17295526 |
| 63 | MP0002877_abnormal_melanocyte_morpholog | 1.15911553 |
| 64 | MP0002396_abnormal_hematopoietic_system | 1.12333619 |
| 65 | MP0003763_abnormal_thymus_physiology | 1.10585847 |
| 66 | MP0010307_abnormal_tumor_latency | 1.08832997 |
| 67 | MP0000920_abnormal_myelination | 1.07836998 |
| 68 | MP0002933_joint_inflammation | 1.02730025 |
| 69 | MP0003724_increased_susceptibility_to | 1.02607793 |
| 70 | MP0003693_abnormal_embryo_hatching | 1.02212950 |
| 71 | MP0003183_abnormal_peptide_metabolism | 1.01860064 |
| 72 | MP0005365_abnormal_bile_salt | 1.01012828 |
| 73 | MP0003866_abnormal_defecation | 0.99933067 |
| 74 | MP0002136_abnormal_kidney_physiology | 0.99744821 |
| 75 | MP0004883_abnormal_blood_vessel | 0.96511992 |
| 76 | MP0002998_abnormal_bone_remodeling | 0.95518353 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 0.95266800 |
| 78 | MP0009764_decreased_sensitivity_to | 0.94652978 |
| 79 | MP0005164_abnormal_response_to | 0.93610276 |
| 80 | MP0005397_hematopoietic_system_phenotyp | 0.92958664 |
| 81 | MP0001545_abnormal_hematopoietic_system | 0.92958664 |
| 82 | MP0002277_abnormal_respiratory_mucosa | 0.92925805 |
| 83 | MP0008004_abnormal_stomach_pH | 0.92833991 |
| 84 | MP0000343_altered_response_to | 0.89306168 |
| 85 | MP0005023_abnormal_wound_healing | 0.89283773 |
| 86 | MP0009763_increased_sensitivity_to | 0.88087399 |
| 87 | MP0000703_abnormal_thymus_morphology | 0.87273193 |
| 88 | MP0000465_gastrointestinal_hemorrhage | 0.84782929 |
| 89 | MP0002019_abnormal_tumor_incidence | 0.83087535 |
| 90 | MP0004782_abnormal_surfactant_physiolog | 0.82872813 |
| 91 | MP0008438_abnormal_cutaneous_collagen | 0.82453151 |
| 92 | MP0003091_abnormal_cell_migration | 0.82362528 |
| 93 | MP0009278_abnormal_bone_marrow | 0.81801177 |
| 94 | MP0009643_abnormal_urine_homeostasis | 0.80145176 |
| 95 | MP0001958_emphysema | 0.79450490 |
| 96 | MP0003795_abnormal_bone_structure | 0.79241444 |
| 97 | MP0001348_abnormal_lacrimal_gland | 0.76589609 |
| 98 | MP0004808_abnormal_hematopoietic_stem | 0.75296733 |
| 99 | MP0001851_eye_inflammation | 0.75210582 |
| 100 | MP0002009_preneoplasia | 0.73413218 |
| 101 | MP0001216_abnormal_epidermal_layer | 0.73407404 |
| 102 | MP0001663_abnormal_digestive_system | 0.72896587 |
| 103 | MP0000604_amyloidosis | 0.72547864 |
| 104 | MP0003077_abnormal_cell_cycle | 0.70941783 |
| 105 | MP0000371_diluted_coat_color | 0.70576665 |
| 106 | MP0000609_abnormal_liver_physiology | 0.70535939 |
| 107 | MP0000249_abnormal_blood_vessel | 0.69843897 |
| 108 | MP0005165_increased_susceptibility_to | 0.69609528 |
| 109 | MP0005257_abnormal_intraocular_pressure | 0.69118493 |
| 110 | MP0004957_abnormal_blastocyst_morpholog | 0.68999595 |
| 111 | MP0003075_altered_response_to | 0.68070805 |
| 112 | MP0005390_skeleton_phenotype | 0.67735278 |
| 113 | MP0008057_abnormal_DNA_replication | 0.66857087 |
| 114 | MP0003828_pulmonary_edema | 0.65698516 |
| 115 | MP0005319_abnormal_enzyme/_coenzyme | 0.65361833 |
| 116 | MP0005174_abnormal_tail_pigmentation | 0.65318914 |
| 117 | MP0002796_impaired_skin_barrier | 0.65198448 |
| 118 | MP0002090_abnormal_vision | 0.65195624 |
| 119 | MP0000767_abnormal_smooth_muscle | 0.65111857 |
| 120 | MP0003186_abnormal_redox_activity | 0.64787213 |
| 121 | MP0004264_abnormal_extraembryonic_tissu | 0.64493073 |
| 122 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.61115724 |
| 123 | MP0008874_decreased_physiological_sensi | 0.60977434 |
| 124 | MP0009765_abnormal_xenobiotic_induced | 0.58429299 |
| 125 | MP0004019_abnormal_vitamin_homeostasis | 0.57422622 |
| 126 | MP0001542_abnormal_bone_strength | 0.56934519 |
| 127 | MP0003634_abnormal_glial_cell | 0.56468943 |
| 128 | MP0000015_abnormal_ear_pigmentation | 0.53265359 |
| 129 | MP0002132_abnormal_respiratory_system | 0.52461802 |
| 130 | MP0005647_abnormal_sex_gland | 0.51432134 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.27649001 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.99132095 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.66215414 |
| 4 | Disinhibition (HP:0000734) | 4.61006665 |
| 5 | Agammaglobulinemia (HP:0004432) | 4.20971832 |
| 6 | Cellulitis (HP:0100658) | 4.02652728 |
| 7 | Colitis (HP:0002583) | 3.92377945 |
| 8 | Recurrent viral infections (HP:0004429) | 3.79606962 |
| 9 | Gastrointestinal stroma tumor (HP:0100723) | 3.74185330 |
| 10 | Interstitial pulmonary disease (HP:0006530) | 3.68625122 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 3.67657627 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.65609834 |
| 13 | Mutism (HP:0002300) | 3.64925558 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.60929021 |
| 15 | Abnormality of macrophages (HP:0004311) | 3.54116776 |
| 16 | Recurrent bronchitis (HP:0002837) | 3.51795976 |
| 17 | Systemic lupus erythematosus (HP:0002725) | 3.48528173 |
| 18 | Pustule (HP:0200039) | 3.48094933 |
| 19 | Inflammation of the large intestine (HP:0002037) | 3.44969884 |
| 20 | Recurrent skin infections (HP:0001581) | 3.33376299 |
| 21 | Gastrointestinal inflammation (HP:0004386) | 3.31872345 |
| 22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.29916912 |
| 23 | Autoimmune thrombocytopenia (HP:0001973) | 3.26173282 |
| 24 | IgM deficiency (HP:0002850) | 3.24533566 |
| 25 | Mediastinal lymphadenopathy (HP:0100721) | 3.22520956 |
| 26 | Stomatitis (HP:0010280) | 3.20218347 |
| 27 | Neurofibrillary tangles (HP:0002185) | 3.16954982 |
| 28 | Vasculitis (HP:0002633) | 3.14765227 |
| 29 | Emphysema (HP:0002097) | 3.05838069 |
| 30 | Hematochezia (HP:0002573) | 3.00372313 |
| 31 | Papilloma (HP:0012740) | 3.00268469 |
| 32 | Verrucae (HP:0200043) | 3.00268469 |
| 33 | Myositis (HP:0100614) | 2.99274379 |
| 34 | Dysostosis multiplex (HP:0000943) | 2.97961608 |
| 35 | Meningitis (HP:0001287) | 2.97597001 |
| 36 | Purpura (HP:0000979) | 2.95546683 |
| 37 | Increased cerebral lipofuscin (HP:0011813) | 2.89025785 |
| 38 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.86099376 |
| 39 | Recurrent cutaneous fungal infections (HP:0011370) | 2.86099376 |
| 40 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.85190515 |
| 41 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.85178169 |
| 42 | Recurrent pneumonia (HP:0006532) | 2.83404828 |
| 43 | Chronic otitis media (HP:0000389) | 2.83293406 |
| 44 | Agnosia (HP:0010524) | 2.82941483 |
| 45 | Osteomyelitis (HP:0002754) | 2.82612676 |
| 46 | Upper motor neuron abnormality (HP:0002127) | 2.77677457 |
| 47 | Gingivitis (HP:0000230) | 2.76250107 |
| 48 | Recurrent lower respiratory tract infections (HP:0002783) | 2.74727344 |
| 49 | Lymphopenia (HP:0001888) | 2.74580932 |
| 50 | Increased IgE level (HP:0003212) | 2.74517962 |
| 51 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.73939499 |
| 52 | Thrombocytosis (HP:0001894) | 2.70290872 |
| 53 | Periodontitis (HP:0000704) | 2.68922071 |
| 54 | Increased serum ferritin (HP:0003281) | 2.64589483 |
| 55 | Apathy (HP:0000741) | 2.63742116 |
| 56 | Diminished motivation (HP:0000745) | 2.63662880 |
| 57 | Neuronal loss in central nervous system (HP:0002529) | 2.63456283 |
| 58 | Nuclear cataract (HP:0100018) | 2.61494354 |
| 59 | Chronic obstructive pulmonary disease (HP:0006510) | 2.60521461 |
| 60 | Obstructive lung disease (HP:0006536) | 2.60521461 |
| 61 | Amyloidosis (HP:0011034) | 2.58901552 |
| 62 | Inappropriate behavior (HP:0000719) | 2.58570156 |
| 63 | Myocardial infarction (HP:0001658) | 2.57762232 |
| 64 | Hepatosplenomegaly (HP:0001433) | 2.57143305 |
| 65 | Mucopolysacchariduria (HP:0008155) | 2.54975366 |
| 66 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.54975366 |
| 67 | Osteolytic defects of the hand bones (HP:0009699) | 2.53951627 |
| 68 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.53951627 |
| 69 | Abnormality of glycolipid metabolism (HP:0010969) | 2.52642780 |
| 70 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.52642780 |
| 71 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.52642780 |
| 72 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.51933317 |
| 73 | Progressive neurologic deterioration (HP:0002344) | 2.50015914 |
| 74 | Restrictive lung disease (HP:0002091) | 2.49834839 |
| 75 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.49605036 |
| 76 | Orchitis (HP:0100796) | 2.45361461 |
| 77 | Abnormality of T cell physiology (HP:0011840) | 2.43961096 |
| 78 | Petechiae (HP:0000967) | 2.43608057 |
| 79 | Recurrent sinusitis (HP:0011108) | 2.38450592 |
| 80 | Nasal polyposis (HP:0100582) | 2.36692042 |
| 81 | Spontaneous hematomas (HP:0007420) | 2.34228340 |
| 82 | Hemoptysis (HP:0002105) | 2.33242457 |
| 83 | Urticaria (HP:0001025) | 2.30198453 |
| 84 | Personality changes (HP:0000751) | 2.29501986 |
| 85 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.27539995 |
| 86 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.27539995 |
| 87 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.27539995 |
| 88 | Skin ulcer (HP:0200042) | 2.25693017 |
| 89 | Glomerulonephritis (HP:0000099) | 2.25421456 |
| 90 | Cerebral inclusion bodies (HP:0100314) | 2.24725872 |
| 91 | Fatigue (HP:0012378) | 2.22420904 |
| 92 | Abnormality of the nasal mucosa (HP:0000433) | 2.21448547 |
| 93 | Sepsis (HP:0100806) | 2.20647671 |
| 94 | Complement deficiency (HP:0004431) | 2.19787036 |
| 95 | Retinal atrophy (HP:0001105) | 2.17070136 |
| 96 | Abnormality of iron homeostasis (HP:0011031) | 2.15824876 |
| 97 | Panhypogammaglobulinemia (HP:0003139) | 2.15285638 |
| 98 | Keratoconjunctivitis sicca (HP:0001097) | 2.14557321 |
| 99 | Chronic sinusitis (HP:0011109) | 2.14021326 |
| 100 | Peritonitis (HP:0002586) | 2.13423229 |
| 101 | T lymphocytopenia (HP:0005403) | 2.13366102 |
| 102 | Pulmonary infiltrates (HP:0002113) | 2.12991321 |
| 103 | Poor head control (HP:0002421) | 2.12960235 |
| 104 | Arterial thrombosis (HP:0004420) | 2.12915169 |
| 105 | Polyneuropathy (HP:0001271) | 2.11600760 |
| 106 | Pathologic fracture (HP:0002756) | 2.11110021 |
| 107 | Malnutrition (HP:0004395) | 2.10330921 |
| 108 | IgA deficiency (HP:0002720) | 2.09864965 |
| 109 | Dementia (HP:0000726) | 2.06995451 |
| 110 | Abnormality of T cells (HP:0002843) | 2.06331545 |
| 111 | Gastrointestinal infarctions (HP:0005244) | 2.01968531 |
| 112 | Metaphyseal irregularity (HP:0003025) | 2.01130465 |
| 113 | Vertebral compression fractures (HP:0002953) | 1.99844173 |
| 114 | Encephalitis (HP:0002383) | 1.99335285 |
| 115 | Global brain atrophy (HP:0002283) | 1.98670706 |
| 116 | Bronchitis (HP:0012387) | 1.97648964 |
| 117 | Hypergammaglobulinemia (HP:0010702) | 1.96814969 |
| 118 | Abnormality of the periventricular white matter (HP:0002518) | 1.96499354 |
| 119 | Prolonged neonatal jaundice (HP:0006579) | 1.94890290 |
| 120 | Leukopenia (HP:0001882) | 1.94799627 |
| 121 | Keratoconjunctivitis (HP:0001096) | 1.94439987 |
| 122 | Peripheral demyelination (HP:0011096) | 1.94297011 |
| 123 | Increased IgM level (HP:0003496) | 1.94111268 |
| 124 | Abnormality of T cell number (HP:0011839) | 1.93923767 |
| 125 | Axonal loss (HP:0003447) | 1.93769993 |
| 126 | Basal ganglia calcification (HP:0002135) | 1.93418372 |
| 127 | Premature loss of primary teeth (HP:0006323) | 1.92308374 |
| 128 | Retrobulbar optic neuritis (HP:0100654) | 1.90639633 |
| 129 | Optic neuritis (HP:0100653) | 1.90639633 |
| 130 | Leukocytosis (HP:0001974) | 1.89035671 |
| 131 | Memory impairment (HP:0002354) | 1.88533147 |
| 132 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.88232727 |
| 133 | Asymmetric septal hypertrophy (HP:0001670) | 1.85635701 |
| 134 | Nephritis (HP:0000123) | 1.85595197 |
| 135 | Loss of speech (HP:0002371) | 1.85100761 |
| 136 | Mitral stenosis (HP:0001718) | 1.84943590 |
| 137 | Gingival bleeding (HP:0000225) | 1.84686973 |
| 138 | Increased CSF protein (HP:0002922) | 1.84479213 |
| 139 | Cardiomegaly (HP:0001640) | 1.83445918 |
| 140 | Reticulocytopenia (HP:0001896) | 1.83016754 |
| 141 | Villous atrophy (HP:0011473) | 1.82927350 |
| 142 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.82927350 |
| 143 | Abnormality of complement system (HP:0005339) | 1.81790742 |
| 144 | Pulmonary embolism (HP:0002204) | 1.81510737 |
| 145 | Supranuclear gaze palsy (HP:0000605) | 1.80939463 |
| 146 | Conjunctival telangiectasia (HP:0000524) | 1.80261266 |
| 147 | Polycythemia (HP:0001901) | 1.80253261 |
| 148 | Bone pain (HP:0002653) | 1.78231924 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.97788876 |
| 2 | ERN1 | 3.61713004 |
| 3 | BLK | 3.59298511 |
| 4 | MAP3K14 | 3.12483185 |
| 5 | TYK2 | 3.03551644 |
| 6 | IRAK3 | 2.67692668 |
| 7 | TBK1 | 2.50201857 |
| 8 | GRK7 | 2.41505331 |
| 9 | STK10 | 2.24379501 |
| 10 | IRAK4 | 2.19877881 |
| 11 | LRRK2 | 2.17214900 |
| 12 | PRPF4B | 2.09965010 |
| 13 | IKBKB | 2.03854953 |
| 14 | MAP3K10 | 1.91746887 |
| 15 | RIPK4 | 1.88388538 |
| 16 | CSF1R | 1.87399570 |
| 17 | JAK3 | 1.80610517 |
| 18 | GRK6 | 1.79678825 |
| 19 | TRIB3 | 1.77592807 |
| 20 | TAOK2 | 1.72483026 |
| 21 | MST4 | 1.71252849 |
| 22 | FES | 1.66615772 |
| 23 | TAOK1 | 1.63243838 |
| 24 | CSK | 1.61970900 |
| 25 | KIT | 1.60229486 |
| 26 | DDR2 | 1.57285236 |
| 27 | MAP3K13 | 1.52578916 |
| 28 | PIM2 | 1.48856356 |
| 29 | NME2 | 1.48589119 |
| 30 | ZAP70 | 1.48313549 |
| 31 | IKBKE | 1.45453978 |
| 32 | JAK1 | 1.45416255 |
| 33 | RPS6KA4 | 1.45152414 |
| 34 | SYK | 1.42043742 |
| 35 | BTK | 1.39449176 |
| 36 | TGFBR2 | 1.39231227 |
| 37 | CHUK | 1.38789649 |
| 38 | CAMKK2 | 1.36643183 |
| 39 | TESK2 | 1.35657724 |
| 40 | BMPR2 | 1.34211435 |
| 41 | TXK | 1.33623625 |
| 42 | PIM1 | 1.33255929 |
| 43 | CDK12 | 1.22840759 |
| 44 | CDC42BPA | 1.18118204 |
| 45 | EPHB1 | 1.16465190 |
| 46 | ABL2 | 1.14857464 |
| 47 | TNK2 | 1.13972369 |
| 48 | MAP3K1 | 1.11647269 |
| 49 | TESK1 | 1.07488638 |
| 50 | NEK9 | 1.06124236 |
| 51 | SCYL2 | 1.06103255 |
| 52 | MATK | 1.05314609 |
| 53 | PKN2 | 1.05092202 |
| 54 | LYN | 1.04112998 |
| 55 | FGFR4 | 1.03523571 |
| 56 | FLT3 | 0.99995618 |
| 57 | SIK3 | 0.98743862 |
| 58 | MAP3K8 | 0.97542405 |
| 59 | PTK6 | 0.96434658 |
| 60 | MAP2K2 | 0.91384893 |
| 61 | MAP2K3 | 0.90459992 |
| 62 | BMX | 0.89100854 |
| 63 | STK4 | 0.88766932 |
| 64 | HCK | 0.84916018 |
| 65 | DYRK1B | 0.84681767 |
| 66 | IRAK2 | 0.82909668 |
| 67 | MAP3K3 | 0.82756263 |
| 68 | TLK1 | 0.82088058 |
| 69 | MST1R | 0.81166362 |
| 70 | ADRBK2 | 0.80943312 |
| 71 | PDK2 | 0.80599836 |
| 72 | MARK3 | 0.79868360 |
| 73 | LCK | 0.78880037 |
| 74 | PAK4 | 0.77691812 |
| 75 | NEK2 | 0.76588420 |
| 76 | EIF2AK3 | 0.75788561 |
| 77 | PDPK1 | 0.75768468 |
| 78 | EPHA2 | 0.75667206 |
| 79 | JAK2 | 0.74581004 |
| 80 | TEC | 0.74301286 |
| 81 | FRK | 0.70162055 |
| 82 | RIPK1 | 0.69806663 |
| 83 | TTN | 0.69516582 |
| 84 | MAP3K11 | 0.68611819 |
| 85 | TAOK3 | 0.68223712 |
| 86 | PDK1 | 0.67055511 |
| 87 | CDK6 | 0.66188040 |
| 88 | MAP3K5 | 0.66124951 |
| 89 | EIF2AK1 | 0.62221301 |
| 90 | FGR | 0.62087622 |
| 91 | DYRK3 | 0.60960774 |
| 92 | FGFR3 | 0.60813907 |
| 93 | MAPKAPK2 | 0.60663291 |
| 94 | IRAK1 | 0.60310698 |
| 95 | MAP2K6 | 0.58023767 |
| 96 | CLK1 | 0.57371487 |
| 97 | KDR | 0.56670987 |
| 98 | EPHA3 | 0.56122703 |
| 99 | RPS6KL1 | 0.55643828 |
| 100 | RPS6KB2 | 0.53047125 |
| 101 | CDK4 | 0.52760239 |
| 102 | ARAF | 0.52696017 |
| 103 | ITK | 0.51163039 |
| 104 | MAPK12 | 0.48420724 |
| 105 | EEF2K | 0.48226181 |
| 106 | DAPK2 | 0.46965870 |
| 107 | KSR2 | 0.46649190 |
| 108 | PRKCD | 0.46113137 |
| 109 | MAPK7 | 0.45086593 |
| 110 | FYN | 0.44420247 |
| 111 | RPS6KA2 | 0.41956127 |
| 112 | CAMKK1 | 0.41945883 |
| 113 | PRKCQ | 0.41587569 |
| 114 | ABL1 | 0.40900245 |
| 115 | EGFR | 0.40833492 |
| 116 | CAMK1D | 0.40811555 |
| 117 | STK3 | 0.40742857 |
| 118 | MAPKAPK3 | 0.40106576 |
| 119 | RPS6KA5 | 0.39710524 |
| 120 | MARK2 | 0.39396677 |
| 121 | TGFBR1 | 0.38884329 |
| 122 | CDK9 | 0.38819831 |
| 123 | SIK1 | 0.38605801 |
| 124 | SIK2 | 0.37867066 |
| 125 | ACVR1B | 0.37051993 |
| 126 | MAP2K1 | 0.36502661 |
| 127 | YES1 | 0.36481000 |
| 128 | RPS6KA6 | 0.36186538 |
| 129 | MAPK4 | 0.34640800 |
| 130 | HIPK2 | 0.33369266 |
| 131 | AURKB | 0.32969410 |
| 132 | MOS | 0.32225717 |
| 133 | PRKG2 | 0.31938614 |
| 134 | GRK1 | 0.30589303 |
| 135 | PRKD2 | 0.30289533 |
| 136 | ILK | 0.30063110 |
| 137 | MAPK11 | 0.29548259 |
| 138 | RPS6KC1 | 0.27854828 |
| 139 | MAP3K6 | 0.24781886 |
| 140 | CAMK1G | 0.22515014 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.88849196 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.88325447 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.79036711 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.62103900 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.48616623 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.37402417 |
| 7 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 2.35139236 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.25933962 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.18729243 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.16221283 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 2.12871125 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.08484903 |
| 13 | Lysosome_Homo sapiens_hsa04142 | 2.01715760 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 1.97420153 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 1.91874278 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.83342266 |
| 17 | Apoptosis_Homo sapiens_hsa04210 | 1.81232543 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 1.80647972 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.78709196 |
| 20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.73954357 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.70911101 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.70187275 |
| 23 | Ribosome_Homo sapiens_hsa03010 | 1.60766701 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.58684997 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.57659027 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.57307559 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.49712155 |
| 28 | Shigellosis_Homo sapiens_hsa05131 | 1.48004180 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.47429386 |
| 30 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.37521266 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.36571540 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.30579761 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26014552 |
| 34 | DNA replication_Homo sapiens_hsa03030 | 1.22704313 |
| 35 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.18100684 |
| 36 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.16613725 |
| 37 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.16108576 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.15575830 |
| 39 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.14505796 |
| 40 | Salmonella infection_Homo sapiens_hsa05132 | 1.10507133 |
| 41 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.08193050 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.07470825 |
| 43 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.07065920 |
| 44 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.06111510 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.05307609 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05112690 |
| 47 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.04053669 |
| 48 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.03070302 |
| 49 | Allograft rejection_Homo sapiens_hsa05330 | 1.02037796 |
| 50 | Base excision repair_Homo sapiens_hsa03410 | 1.00790567 |
| 51 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.99613896 |
| 52 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.98731854 |
| 53 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.98616900 |
| 54 | Phagosome_Homo sapiens_hsa04145 | 0.94331121 |
| 55 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.93839769 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 0.90702834 |
| 57 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90668385 |
| 58 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.90293598 |
| 59 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.89835330 |
| 60 | Mismatch repair_Homo sapiens_hsa03430 | 0.88171399 |
| 61 | Hepatitis C_Homo sapiens_hsa05160 | 0.87615237 |
| 62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86478672 |
| 63 | Proteasome_Homo sapiens_hsa03050 | 0.85659078 |
| 64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.84335883 |
| 65 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.82944336 |
| 66 | Prion diseases_Homo sapiens_hsa05020 | 0.80352794 |
| 67 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.77765382 |
| 68 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.76311673 |
| 69 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75359375 |
| 70 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.74814852 |
| 71 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.71118291 |
| 72 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.70735044 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68743451 |
| 74 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.68669370 |
| 75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68084681 |
| 76 | HTLV-I infection_Homo sapiens_hsa05166 | 0.66641384 |
| 77 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.66082661 |
| 78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65768933 |
| 79 | Asthma_Homo sapiens_hsa05310 | 0.64678571 |
| 80 | Sulfur relay system_Homo sapiens_hsa04122 | 0.62182121 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61560945 |
| 82 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.61017528 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59709148 |
| 84 | Platelet activation_Homo sapiens_hsa04611 | 0.56879031 |
| 85 | Mineral absorption_Homo sapiens_hsa04978 | 0.55259917 |
| 86 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.53045972 |
| 87 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.52732904 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52466106 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52010820 |
| 90 | Amoebiasis_Homo sapiens_hsa05146 | 0.51683430 |
| 91 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.51429536 |
| 92 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.49494453 |
| 93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48028462 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46794881 |
| 95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46553799 |
| 96 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.44595029 |
| 97 | Homologous recombination_Homo sapiens_hsa03440 | 0.43846920 |
| 98 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.42717512 |
| 99 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.41363530 |
| 100 | Adherens junction_Homo sapiens_hsa04520 | 0.40624892 |
| 101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.40590321 |
| 102 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39919736 |
| 103 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.38373697 |
| 104 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.37673836 |
| 105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37138282 |
| 106 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36997924 |
| 107 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36669519 |
| 108 | Insulin resistance_Homo sapiens_hsa04931 | 0.36641568 |
| 109 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35067583 |
| 110 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.33775938 |
| 111 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33766760 |
| 112 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.32556165 |
| 113 | Endocytosis_Homo sapiens_hsa04144 | 0.32540154 |
| 114 | Bladder cancer_Homo sapiens_hsa05219 | 0.32186701 |
| 115 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.27715353 |
| 116 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.26933660 |
| 117 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.25079140 |
| 118 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.20480127 |
| 119 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.18913593 |
| 120 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.18533548 |
| 121 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.15132656 |
| 122 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.14837336 |

